Skip to main content

Published locations for ‘Milestone’ Study Zeros in on 5-Year Safety Data From Upadacitinib Trials

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ‘Milestone’ Study Zeros in on 5-Year Safety Data From Upadacitinib Trials

User login

  • Reset your password
  • /content/milestone-study-zeros-5-year-safety-data-upadacitinib-trials
  • /clinicianreviews/article/267177/atopic-dermatitis/milestone-study-zeros-5-year-safety-data
  • /edermatologynews/article/267177/atopic-dermatitis/milestone-study-zeros-5-year-safety-data
  • /familypracticenews/article/267177/atopic-dermatitis/milestone-study-zeros-5-year-safety-data
  • /internalmedicinenews/article/267177/atopic-dermatitis/milestone-study-zeros-5-year-safety-data
  • /pediatricnews/article/267177/atopic-dermatitis/milestone-study-zeros-5-year-safety-data-upadacitinib
  • /pediatrics/article/267177/atopic-dermatitis/milestone-study-zeros-5-year-safety-data-upadacitinib
  • /internalmedicine/article/267177/atopic-dermatitis/milestone-study-zeros-5-year-safety-data
  • /dermatology/article/267177/atopic-dermatitis/milestone-study-zeros-5-year-safety-data-upadacitinib
  • /familymedicine/article/267177/atopic-dermatitis/milestone-study-zeros-5-year-safety-data